Patents-Review.com
🔗 Permalink
Inventor profile of:

Patton E. Garay

City:

Long Beach, California

Country:

United States

Published Applications:

24

Last publication date:

2023-09-07

Top Assignees for applications by Patton E. Garay

The entities that hold a legal rights for patent applications filed by inventor Garay Patton E.:

Recent patent applications by Garay Patton E.

Patton E. Garay from Long Beach, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-07
US20230279083A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #2 | 2023-07-27
US20230235031A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #3 | 2022-05-12
US20220144925A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #4 | 2021-11-04
US20210340229A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

 #5 | 2021-06-10
US20210171614A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

 #6 | 2013-09-05
US20130230502A1
Human necessities

METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES

 #7 | 2013-08-29
US20130224178A1
Human necessities

Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases

 #8 | 2013-08-01
US20130195838A1
Human necessities

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

 #9 | 2013-02-14
US20130040368A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #10 | 2012-08-16
US20120207743A1
Chemistry; metallurgy

Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases

 #11 | 2012-08-16
US20120207742A1
Chemistry; metallurgy

Treatments Using PSMA Ligand Endopeptidases

 #12 | 2012-08-16
US20120207734A1
Human necessities

Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases

 #13 | 2012-08-16
US20120207733A1
Human necessities

Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases

 #14 | 2012-08-16
US20120207704A1
Chemistry; metallurgy

Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases

 #15 | 2011-05-12
US20110110911A1
Human necessities

Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases

 #16 | 2011-03-24
US20110070215A1
Human necessities

METHODS OF TREATING CANCER USING NEUROTROPHIN RETARGETED ENDOPEPTIDASES

 #17 | 2011-03-24
US20110070212A1
Human necessities

Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases

 #18 | 2011-03-24
US20110070211A1
Human necessities

Methods of Treating Cancer Using Galanin Retargeted Endopepidases

 #19 | 2011-03-24
US20110070186A1
Human necessities

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

 #20 | 2011-03-17
US20110064713A1
Human necessities

Methods of Treating Cancer Using Opioid Retargeted Endopepidases

 #21 | 2009-12-24
US20090317839A1
Physics

Botulinum toxin screening assays

 #22 | 2009-10-22
US20090263836A1
Physics

Botulinum toxin screening assays

 #23 | 2008-07-31
US20080182799A1
Physics

Botulinum toxin screening assays

 #24 | 2008-01-03
US20080003240A1
Physics

Botulinum toxin screening assays
InventorID:

90393 ⎘